GC Aesthetics, a provider of silicone breast implants in Latin America and EMEA, withdrew its plans for an initial public offering on Wednesday. The company had postponed its IPO in early August 2015 after setting terms to raise $75 million.
The Dublin, Ireland-based company, which initially filed confidentially on May 15, 2015, booked $55 million in sales for the 12 months ended March 31, 2015. BofA Merrill Lynch, Deutsche Bank and Cowen & Company were set to be the joint bookrunners for the IPO....more
Capitol Acquisition Corp., a blank check company headed by Mark Ein, filed on Monday with the SEC to raise up to $350 million in an initial public offering.
The Washington, D.C.-based company, which was founded in 2015, plans to list on the Nasdaq. Citi is the sole bookrunner on the deal. No pricing terms were disclosed....more
Sancilio Pharmaceuticals Company, which markets, licenses and develops products based on its lipid drug delivery technology, filed on Monday with the SEC to raise up to $86 million in an initial public offering.
The Riviera Beach, FL-based company, which was founded in 2006 and booked $22 million in revenue for the 12 months ended June 30, 2015, plans to list on the Nasdaq under the symbol [SPCI]. Sancilio Pharmaceuticals initially filed confidentially on May 14, 2015. UBS Investment Bank, Piper Jaffray, JMP Securities and FBR Capital Mark...more
PharMEDium Healthcare Holdings, a national provider of compounded sterile preparations to acute care hospitals, filed on Monday with the SEC to raise up to $100 million in an initial public offering. However, we believe this could be a placeholder for a larger offering.
The Lake Forest, IL-based company, which was founded in 2003 and booked $430 million in sales for the 12 months ended June 30, 2015, plans to list on the NYSE under the symbol [PMHC]. Credit Suisse, J.P. Morgan, Morgan Stanley, BofA Merrill Lynch and Goldman Sachs are the j...more